TAK-164

· Millennium Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAK-164, covering 2021-03-22 to 2021-03-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TAK-164 in Participants With Advanced Gastrointestinal (GI) Cancer Expressing Guanylyl Cyclase C (GCC) [Phase 1]

See pricing